Acumen Pharmaceuticals ABOS
NASDAQ ABOS
$2.03 +0.01 (+0.74%)
As of: Oct 21, 2026 · 11:01 AM EDT

Acumen Pharmaceuticals (ABOS) Total Debt (2023 - 2026)

Updated

Acumen Pharmaceuticals (ABOS) reported Total Debt of $19.67 million for Q2 2026, up 39.3% from the prior quarter.

Analysis

Acumen Pharmaceuticals (ABOS) Total Debt (2023 - 2026) Analysis & Trends

At the end of FY2025, Acumen Pharmaceuticals posted Total Debt of $8.77 million.

  • Per Business Quant data, the three quarters before Q2 2026 came in at $14.12 million (Q1 2026), $8.77 million (Q4 2025) and $3.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,131.80 Bn 1,100.39 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 614.01 Bn 532.53 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.59 Bn 476.70 Bn 12.70 Bn 70.82 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.81 Bn 261.80 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.50 Bn 235.19 Bn 12.86 Bn 32.35 Bn
7 Amgen 236.24 Bn 191.64 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.15 Bn 165.35 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.16 Bn 116.81 Bn 10.94 Bn 63.19 Bn
10 Acumen Pharmaceuticals 146.67 Mn -335.40 Mn - 31.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.57 Mn
Mar 31, 2026 31.05 Mn
Dec 31, 2025 31.16 Mn
Sep 30, 2025 30.65 Mn
Jun 30, 2025 29.88 Mn
Mar 31, 2025 29.53 Mn
Dec 31, 2024 29.42 Mn
Sep 30, 2024 29.67 Mn
Jun 30, 2024 29.38 Mn
Mar 31, 2024 30.21 Mn
Dec 31, 2023 29.90 Mn
API Access

Acumen Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ABOS&period=max&api_key=YOUR_API_KEY